Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.43B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Dianthus Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 269
- +30 vs. Q1 2026
- Shares held
- 66.0M
- +1.64M (+2.5%) vs. Q1 2026
- Total value
- $6.43B
- +$1.05B (+19.6%) vs. Q1 2026
- New holders
- 63
- 116 more added
- Sold out
- 33
- 69 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.43B |
| Q1 2026 | 241 | $5.37B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.85B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $859.0M |
| Q2 2024 | 74 | $769.0M |
| Q1 2024 | 76 | $784.0M |
| Q4 2023 | 39 | $109.9M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 8,199,893 | $799.3M | 0.03% | +432,207+5.6% | Added |
| BlackRock, Inc. | 4,123,822 | $402.0M | 0.01% | +948,119+29.9% | Added |
| T. Rowe Price Investment Management, Inc. | 3,888,456 | $379.0M | 0.25% | +2,596,274+200.9% | Added |
| Wellington Management Group LLP | 3,229,882 | $314.8M | 0.05% | +634,099+24.4% | Added |
| Fairmount Funds Management LLC | 2,537,191 | $247.3M | 16.35% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,514,946 | $245.2M | 0.02% | +1,367,998+119.3% | Added |
| State Street Corp | 2,357,440 | $229.8M | 0.01% | +958,527+68.5% | Added |
| Vanguard Capital Management LLC | 2,159,568 | $210.5M | 0.00% | +128,319+6.3% | Added |
| Avidity Partners Management LP | 2,104,184 | $205.1M | 32.85% | −2,104,184−50.0% | Reduced |
| Octagon Capital Advisors LP | 1,841,667 | $179.5M | 16.48% | −105,000−5.4% | Reduced |
| TCG Crossover Management, LLC | 1,676,624 | $163.4M | 3.93% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 1,302,493 | $127.0M | 0.42% | +140,570+12.1% | Added |
| Geode Capital Management, LLC | 1,258,502 | $122.7M | 0.01% | +342,291+37.4% | Added |
| VR Adviser, LLC | 1,180,000 | $115.0M | 3.49% | 00.0% | Unchanged |
| UBS Group AG | 1,140,260 | $111.2M | 0.02% | +358,978+45.9% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,125,313 | $109.7M | 1.14% | +105,500+10.3% | Added |
| Jennison Associates LLC | 1,021,763 | $99.6M | 0.06% | +536,627+110.6% | Added |
| Polar Capital Holdings Plc | 1,018,726 | $99.3M | 0.28% | −57,283−5.3% | Reduced |
| Citadel Advisors LLC | 974,911 | $95.0M | 0.05% | −635,572−39.5% | Reduced |
| Franklin Resources Inc | 968,983 | $94.5M | 0.02% | +801+0.1% | Added |
| Baker Bros. Advisors LP | 852,164 | $83.1M | 0.42% | 00.0% | Unchanged |
| Logos Global Management LP | 800,000 | $78.0M | 3.36% | +400,000+100.0% | Added |
| Cormorant Asset Management, LP | 750,000 | $73.1M | 3.75% | −200,000−21.1% | Reduced |
| Alliancebernstein L.P. | 834,150 | $70.0M | 0.02% | −91,921−9.9% | Reduced |
| Braidwell LP | 594,562 | $58.0M | 2.14% | −304,802−33.9% | Reduced |
| Vanguard Portfolio Management LLC | 570,115 | $55.6M | 0.00% | +220,734+63.2% | Added |
| Assenagon Asset Management S.A. | 561,298 | $54.7M | 0.04% | +561,298 | New |
| Ameriprise Financial Inc | 531,999 | $51.9M | 0.01% | +102,872+24.0% | Added |
| Woodline Partners LP | 500,548 | $48.8M | 0.15% | +67,091+15.5% | Added |
| Barclays PLC | 431,753 | $42.1M | 0.01% | +52,147+13.7% | Added |
| Lord, Abbett & Co. LLC | 422,185 | $41.2M | 0.12% | +122,975+41.1% | Added |
| MPM Oncology Impact Management LP | 420,002 | $40.9M | 2.50% | −3,980−0.9% | Reduced |
| Northern Trust Corp | 411,791 | $40.1M | 0.00% | +108,039+35.6% | Added |
| Affinity Asset Advisors, LLC | 400,000 | $39.0M | 1.91% | +50,000+14.3% | Added |
| Silverarc Capital Management, LLC | 390,000 | $38.0M | 4.23% | −264,746−40.4% | Reduced |
| Goldman Sachs Group Inc | 382,161 | $37.3M | 0.00% | −165,849−30.3% | Reduced |
| Charles Schwab Investment Management Inc | 365,963 | $35.7M | 0.00% | +60,523+19.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 362,470 | $35.3M | 2.10% | 00.0% | Unchanged |
| Spruce Street Capital LP | 354,816 | $34.6M | 6.79% | −18,458−4.9% | Reduced |
| Vivo Capital, LLC | 353,998 | $34.5M | 3.15% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 321,503 | $31.3M | 0.01% | −3,937−1.2% | Reduced |
| Westfield Capital Management Co LP | 314,914 | $30.7M | 0.10% | +314,914 | New |
| Vanguard Fiduciary Trust Co | 302,482 | $29.5M | 0.01% | +52,803+21.1% | Added |
| Driehaus Capital Management LLC | 295,266 | $28.8M | 0.17% | −22,046−6.9% | Reduced |
| First Turn Management, LLC | 285,771 | $27.9M | 2.98% | +64,850+29.4% | Added |
| Tang Capital Management LLC | 264,692 | $25.8M | 1.17% | 00.0% | Unchanged |
| Artisan Partners Limited Partnership | 258,269 | $25.2M | 0.04% | −123,852−32.4% | Reduced |
| Bank of America Corp | 256,833 | $25.0M | 0.00% | +68,054+36.0% | Added |
| Bank of New York Mellon Corp | 256,393 | $25.0M | 0.00% | +67,981+36.1% | Added |
| RTW Investments, LP | 248,063 | $24.2M | 0.21% | 00.0% | Unchanged |
| Emerald Advisers, LLC | 247,805 | $24.2M | 0.57% | +247,805 | New |
| Pictet Asset Management Holding SA | 247,295 | $24.1M | 0.02% | +242,371+4,922.2% | Added |
| TD Asset Management Inc | 225,334 | $22.0M | 0.02% | +108,758+93.3% | Added |
| Eventide Asset Management, LLC | 225,261 | $22.0M | 0.29% | 00.0% | Unchanged |
| LMR Partners LLP | 223,995 | $21.8M | 0.16% | +107,551+92.4% | Added |
| Candriam Luxembourg S.C.A. | 204,214 | $19.9M | 0.09% | −9,308−4.4% | Reduced |
| StemPoint Capital LP | 200,851 | $19.6M | 3.39% | +29,847+17.5% | Added |
| Qube Research & Technologies Ltd | 196,924 | $19.2M | 0.02% | +166,570+548.8% | Added |
| Samlyn Capital, LLC | 196,326 | $19.1M | 0.32% | −234,789−54.5% | Reduced |
| Nicholas Investment Partners, LP | 186,769 | $18.2M | 1.03% | +135,519+264.4% | Added |
| Adage Capital Partners GP, L.L.C. | 185,000 | $18.0M | 0.03% | +25,000+15.6% | Added |
| Ensign Peak Advisors, Inc | 174,187 | $17.0M | 0.03% | −30,149−14.8% | Reduced |
| TimesSquare Capital Management, LLC | 166,357 | $16.2M | 0.24% | +166,357 | New |
| Atika Capital Management LLC | 165,000 | $16.1M | 1.60% | +36,200+28.1% | Added |
| Artia Global Partners LP | 162,990 | $15.9M | 3.02% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 162,005 | $15.8M | 0.03% | −312,080−65.8% | Reduced |
| Neuberger Berman Group LLC | 157,574 | $15.4M | 0.01% | +98,498+166.7% | Added |
| Alyeska Investment Group, L.P. | 150,592 | $14.7M | 0.04% | +98,345+188.2% | Added |
| Russell Investments Group, Ltd. | 143,431 | $14.0M | 0.01% | +14,366+11.1% | Added |
| Eagle Health Investments LP | 131,344 | $12.8M | 2.12% | +131,344 | New |
| Emerald Mutual Fund Advisers Trust | 131,018 | $12.8M | 0.45% | +131,018 | New |
| Marshall Wace, LLP | 128,743 | $12.5M | 0.01% | −213,186−62.3% | Reduced |
| PFM Health Sciences, LP | 121,222 | $11.8M | 1.03% | −50,915−29.6% | Reduced |
| Tri Locum Partners LP | 120,712 | $11.8M | 1.45% | −24,831−17.1% | Reduced |
| Nuveen, LLC | 119,460 | $11.6M | 0.00% | −98,022−45.1% | Reduced |
| OrbiMed Advisors LLC | 115,000 | $11.2M | 0.21% | +115,000 | New |
| Patient Square Capital LP | 108,000 | $10.5M | 1.63% | +14,118+15.0% | Added |
| Two Sigma Investments, LP | 107,455 | $10.5M | 0.01% | +107,455 | New |
| Morgan Stanley | 106,376 | $10.4M | 0.00% | +8,921+9.2% | Added |
| Seven Grand Managers, LLC | 100,000 | $9.75M | 0.39% | 00.0% | Unchanged |
| First Trust Advisors LP | 94,152 | $9.18M | 0.01% | +94,152 | New |
| SEI Investments Co | 92,280 | $8.99M | 0.01% | +51+0.1% | Added |
| Millennium Management LLC | 91,838 | $8.95M | 0.01% | −170,124−64.9% | Reduced |
| Victory Capital Management Inc | 88,315 | $8.61M | 0.00% | +72,653+463.9% | Added |
| American Century Companies Inc | 87,860 | $8.56M | 0.00% | +8,764+11.1% | Added |
| Rhenman & Partners Asset Management AB | 86,127 | $8.40M | 0.79% | +4,500+5.5% | Added |
| Invesco Ltd. | 85,603 | $8.34M | 0.00% | −45,144−34.5% | Reduced |
| UBS Asset Management Americas Inc | 75,396 | $7.35M | 0.00% | +14,961+24.8% | Added |
| Moody Aldrich Partners LLC | 74,552 | $7.27M | 1.31% | −7,577−9.2% | Reduced |
| Swiss National Bank | 73,800 | $7.19M | 0.00% | +4,800+7.0% | Added |
| Deutsche Bank AG | 69,756 | $6.80M | 0.00% | +38,296+121.7% | Added |
| Mercer Global Advisors Inc | 65,683 | $6.40M | 0.01% | +65,683 | New |
| LPL Financial LLC | 65,295 | $6.37M | 0.00% | +24,471+59.9% | Added |
| Seven Fleet Capital Management LP | 64,723 | $6.31M | 1.04% | −16,086−19.9% | Reduced |
| SummitTX Capital, L.P. | 63,866 | $6.23M | 0.16% | −36,178−36.2% | Reduced |
| Manufacturers Life Insurance Company, The | 62,829 | $6.12M | 0.00% | −2,409−3.7% | Reduced |
| New York State Common Retirement Fund | 60,048 | $5.85M | 0.01% | +12,076+25.2% | Added |
| Sio Capital Management, LLC | 59,254 | $5.78M | 0.99% | −310,791−84.0% | Reduced |
| Rhumbline Advisers | 58,521 | $5.70M | 0.00% | +13,335+29.5% | Added |
| Jones Hill Capital LP | 57,100 | $5.57M | 1.18% | +57,100 | New |